NCT03617250View on ClinicalTrials.gov

Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

August 1, 2022

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Disease Activity Score-28

Assessment of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio and their association with Disease Activity Score-28

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03617250 - Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter